Preemption Redemption: FDA Legal Briefs Stand In For Product Liability Law

FDA's new-found willingness to invoke the federal preemption doctrine in state tort suits may provide device firms with some solace in the absence of product liability reform legislation, but prospects remain unclear for non-original-PMA devices

More from Archive

More from Medtech Insight